First in Man Oral
and Parenteral Dosage Forms
SEE ARTICLE
Early-Stage, IND-Enabling Formulations
for PK & Toxicoloxy Studies
SEE ARTICLE
Rapid Development Through
Phase I Clinical Trial Materials
SEE ARTICLE
Formulations for Poorly Soluble
& Low Bioavailability Drugs
SEE ARTICLE
Sophisticated formulations in every stage of development from MOLECULE to FORMULATION to CLINICAL
Our Technologies
A wide array of pharmaceutical development capabilities for manufacturing and analyzing drug product dosage forms. READ MORE >
Ascendia Solidifies Leading CDMO Position By Ranking on Inc. 5000 List Again
Ascendia Pharmaceuticals solidified its position as a leading pharmaceutical contract formulation development and manufacturing organization (CDMO) by once again being […]
SEE ARTICLEPARTNERING WITH ASCENDIA
Ascendia provides its partners rapid, comprehensive and cost-effective solutions for their difficult formulation development projects. LEARN MORE >
ASCENDIA NEWSROOM
![](https://ascendiapharma.com/hs-fs/hubfs/LNP_mRNA.jpg?width=255&name=LNP_mRNA.jpg)
Lipid nanoparticles (LNPs) have gained so much attention due to the launch of vaccines and therapeutics in the past few years. Com […]
READ MORE >![](https://ascendiapharma.com/hs-fs/hubfs/ASC-Blog_Thumb-2024-Ascendia%20Pharma-%20Innovating%20the%20Future%20%20of%20CDMO%20Drug%20Manufacturing%20%281%29.jpg?width=255&name=ASC-Blog_Thumb-2024-Ascendia%20Pharma-%20Innovating%20the%20Future%20%20of%20CDMO%20Drug%20Manufacturing%20%281%29.jpg)
Ascendia® Pharma has invested in talent, technology, and manufacturing space to now offer pharmaceutical and biological drug devel […]
READ MORE >![](https://ascendiapharma.com/hs-fs/hubfs/ASC-Blog_Thumb-2024-05-Using-Advanced-Strategies.jpg?width=255&name=ASC-Blog_Thumb-2024-05-Using-Advanced-Strategies.jpg)
At first glance, dose formulation services may appear to be fairly ubiquitous across the industry, although there are many nuances […]
READ MORE >
Want to learn more about
Ascendia's expertise?
Get up-to-date information